Program Sponsors

Scientific Program

April 30

 

SUNDAY APRIL 30

 
Time Session Location

0800-1200

Committee Meetings

0800-1630

Fellow Education Day

1000-1045

Exam Skills

Speakers:

Aspasia Karalis, Service de génétique médicale, CHU Sainte-Justine, Montréal QC

Ryan Lamont, Molecular Diagnostics Laboratory, Alberta Children's Hospital, Calgary AB

1045-1100

Refreshment Break

1100-1150

Quality Assurance of Lab Developed Tests

Speaker:

Tracey Stockley, Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto ON

1200-1300

Lunch with Trainees (provided)

1315-1400

Career Paths

Speaker:

Bridget Fernandez, St John's Health Sciences Centre, St. John’s NL

1400-1500

How to write your CV and cover letter

Speakers:

Julie Richer, Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa ON

Karen Niederhoffer, TBD

Aspasia Karalis, Service de génétique médicale, CHU Sainte-Justine, Montréal QC

Jim Stavropoulos, Hospital for Sick Children, Toronto ON

Anne Marie Laberge, CHU Sainte-Justine, Montréal QC

1500-1515

Refreshment Break

1515-1615

How to write a manuscript and select a journal

Speaker:

Philippe Campeau, Department of Pediatrics, Université de Montréal, Sainte-Justine Hospital, Montréal QC

Viger

1200-1300

Lunch with Trainees (provided)

1700-1850

Keynote Address & Award Presentation

Montreal AB

 

1700-1710

Welcome Remarks - President Judy Chernos

Chair: Judy Chernos, Cytogenetics Laboratory, Alberta Children's Hospital, Calgary, AB

1710-1800

Keynote Presentation

1710-1715

Introduction of Keynote Speaker by Gail Graham

1715-1800

Title: Bill S201- The Journey towards genetic fairness in Canada

Speaker: Bev Heim-Meyers - CEO Huntington Society of Canada & Chair Canadian Coalition for Genetic Fairness

Objectives: At the end of the session, the participants will be able to:

  •  
 1800-1815 Questions and Discussion
 1815-1850

The F. Clarke Fraser Award for Excellence in Mentorship and Teaching Presentation

 1815-1825

Remembrances of F. Clarke Fraser - Dr. Marilyn Preus

 1825-1840 Introduction of Dr. Charles Scriver - inaugural recipient of the F. Clarke Fraser Award
 1840-1850 Presentation of Award and acceptance speech Dr. C. Scriver
1900-2200

Welcome Reception

Grande Place

 

May 1

 

MONDAY MAY 1

 

Tme Session Location
0700-0800

Industry Breakfast Seminar
GeneDX

Montreal C

0800-1140

Symposium 1

CNV and New Pathogenic Models in Neurodevelopmental Disorders

Chair: Frederique Tihy, Service de Génétique Médicale, CHU Ste-Justine, Montréal QC

Montreal AB

 

 

0800-0815

Opening Remarks

0815-0850

Pathogenic CNVs, the adult phenotype, and counselling about long term outcome
Speaker: Anne Bassett, Department of Psychiatry, University of Toronto, Toronto ON

Objectives: At the end of the session, the participants will be able to:

  •  

0850-0900

Q & A

0900-0935

Challenges of CNV interpretation in clinical practice
Speaker: Melissa Carter, Children’s Hospital of Eastern Ontario, Ottawa ON

Objectives: At the end of the session, the participants will be able to:

  •  

0935-0945

Q & A

0945-1015

Refreshment Break

1015-1050

Gene Dosage effects on cognition and additive/oligogenic models in the neurodevelopmental clinic
Speaker: Sebastien Jacquemont, Hôpital Ste-Justine, Montréal QC

Objectives: At the end of the session, the participants will be able to:

  • Understand the heritability of cognitive and behavioral traits
  • Understand the quantitative effects of genomic variants on cognitive and behavioral traits
  • Use available data to understand the contribution of genomic variants to the symptoms present in patients referred for a neurodevelopmental disorder.
  • Understand the implication of these studies on genetic counselling

1050-1100

 Q & A Session

1100-1135

Copy Number Variants in Neurodevelopmental Disorders
Speaker: Christian Marshall, Hospital for Sick Children, Toronto ON

At the end of the session, the participants will be able to:

  •  

Montreal AB

 

1135-1145

Q & A Session

1145-1345

CCMG Annual General Meeting, Award Presentations & Lunch

Hamerton Award Presentation - Janet Buchanan
Founders' Award Presentation - Cheryl Greenberg-Rockman

Open to all attendees.

Montreal AB

1345-1715

Symposium 2

WES, Metabolic & Mitochondrial Disorders

Chair: David Chitayat, Professor, Department of Pediatrics, Obstetrics & Gynaecology, Laboratory Medicine & Pathobiology & Molecular Genetics, University of Toronto, Toronto, ON

Montreal AB

 

1345-1420

Title: TBD

Speaker: Grant Mitchell, Service de génétique médicale, Hôpital Ste-Justine, Montréal QC

Objectives: At the end of the session, the participants will be able to:

  •  

1420-1430

Q & A Session

1430-1505

Neurodegeneration when iron is the culprit

Speaker: Patrick MacLeod, Medical Genetics, Department Office, University of British Columbia

Objectives: At the end of the session, the participants will be able to:

  • Summarize the biology of iron metabolism
  • Discuss the role of iron in the brain
  • Discuss the various forms of neurodegeneration with brain iron accumulation
  • List the genes involved in NBIA

1505-1515

Q & A

1515-1545

Refreshment Break

Montreal Foyer

1545-1620

Title: Peroxisome biogenesis disorders and related single enzyme defects: clinical updates and pre-clinical approaches to targeted therapies.

Speaker: Nancy Braverman, McGill University, Montréal QC

At the end of the session, the participants will be able to:

  • Integrate newly described peroxisome disorders
  • Formulate a diagnostic model for the different peroxisome disorders
  • Describe new contributions to peroxisome biology
    Appraise preclinical approaches to therapy

Montreal AB

 

1620-1630

Q & A Session

1630-1710

Title: TBD
Speaker: Eric Shoubridge, McGill University, Montréal QC

At the end of the session, the participants will be able to:

  •  

Montreal AB

 

1710-1715

 Q & A Session

1715-1815

Poster Presentations - Interactive session with the authors of poster presentations

Grande Place

1715-1930

Wine & Cheese Reception in Exhibit Hall

Grande Place

 

May 2

 

TUESDAY MAY 2

 

Time Session Location

0700-0800

Light Breakfast with the Exhibitors

Grande Place

0700-0800

Industry Breakfast Seminar
AstraZeneca

Montreal C

0700-0800

Industry Breakfast Seminar
PreventionGenetics

Montreal D

0800-1200

Symposium 3 - Population Genetics / Founder Effects

Chair: Micheil Innes, Department of Medical Genetics, Alberta Children’s Hospital, Calgary AB

Montreal AB

 

 

 

0800-0815

Opening Remarks

0815-0850

The Importance of Peace of Mind: Lessons Learned from the Evaluation of a Community-based Carrier Screening Program in First Nations Communities

Speaker: Anne Marie Laberge, CHU Sainte-Justine, Montréal QC

Objectives: At the end of the session, the participants will be able to:

  • Describe the carrier screening program for Cree encephalitis and Cree leukoencephalopathy in the Cree communities of James Bay
  • Discuss the importance of adapting a program to the target population's needs and values
  • Use the lessons learned in this setting to their own practice when counseling individuals and couples about carrier screening for recessive conditions

0850-0900

Q & A Session

0900-0935

Title: The Great Migration and African-American genomic diversity

Speaker: Simon Gravel, McGill University. Montréal QC

Objectives: At the end of the session, the participants will be able to:

  • Describe how recent history affected genomic diversity
  • Build models of genetic admixture
  • Build models of genetic relatedness

0935-0945

Q & A Session

0945-1015

Refreshment Break - Grande Place

1015-1050

Title: TBD

Speaker: Victoria Siu, Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London ON

Objectives: At the end of the session, the participants will be able to:

  •  

1050-1100

Q & A Session

1100-1135

From Gene Discovery to Provision of Genomic Medicine in the Hutterite Population

Cheryl Rockman-Greenberg, Pediatrics and Child Health, Children's Hospital Health Science Centre, Winnipeg MB
Beth Spriggs, Dept. of Clinical Biochemistry and Genetics, Diagnostic Services Manitoba, Health Sciences Centre, Winnipeg MB

Objectives: At the end of the session, the participants will be able to:

  • Name at least 3 autosomal recessive diseases unique to Hutterites where the mutations are known.
  • Define what the “Hutterite Chip” is and its main role in diagnostics.
  • Describe the molecular technology behind the “Hutterite Chip”.
  • Assess the pros and cons of implementing a “Hutterite Chip” into medical practice.
  • Discuss the ethical concerns.

1135-1145

Q & A Session

1145-1220

Late Breaking Session - The Power of Genome-Wide DNA Methylation: A functional tool for classifying mutations

Speaker: Rosanna Weksberg, Department of Genetics, Hospital for Sick Children, Toronto ON

Objectives: At the end of the session, the participants will be able to:

  •  

Montreal AB

 

1220-1230

Q & A Session

1220-1430

Lunch with Exhibitors

Grande Place

1430-1530

CCMG Trainees Platform Presentations - Selected abstracts

Chair: David Chitayat, The Hospital for Sick Children, Mt. Sinai Hospital, Toronto ON

Montreal AB

1430-1440


TBD - TBD

 

1440-1445

Q & A

 

1445-1455

TBD - TBD

 

1455-1500

Q & A

 

1500-1510

TBD - TBD

 

1510-1515

Q & A

 

1515-1525

TBD - TBD

 

1525-1530

Q & A

 

1530-1600

Refreshment Break with the Exhibitors

Grande Place

1630-1730

2 Breakout Sessions

Montreal C / D

BREAKOUT SESSION 1

1600-1715

Clinical/Biochemical  Breakout

Moderators: Oana Caluseriu, Department of Medical Genetics, University of Alberta, Edmonton AB

Murray Potter, Laboratory Medicine, McMaster Children’s Hospital, Hamilton ON

Objectives: At the end of the session, the participants will be able to:

  •  

Montreal C

 

1715-1730

Q & A Session

BREAKOUT SESSION 2

1600-1715

Molecular/Cyto Breakout

Moderators: Hanxin Lin, London ON

Dennis Bulman, Research Institute & Newborn Screening Ontario, Children’s Hospital of Eastern Ontario, Ottawa ON

 

Objectives: At the end of the session, the participants will be able to:

  •  

Montreal D

 

1715-1730

Q & A Sessions

1830-2330

The Gala (formerly the Founders Dinner)

Offsite

 

May 3

 

WEDNESDAY MAY 3

 

Time Session Location

0700-0800

Light Breakfast with the Exhibitors

Grande Place

0700-0800

Industry Breakfast Seminars
Blueprint Genetics

Montreal C

0800-1200

Symposium 4

Humanities in Genetics

Chair: Malgorzata Joanna Nowaczyk, Division of Genetics, McMaster University Medical Centre, Hamilton ON

Montreal AB

 

0800-0815 Opening Remarks

0815-0855

The Narrative Tool Kit

Speaker: TBD

Objectives: At the end of the session, the participants will be able to:

  •  

0850-0900

Q & A Session

0855-0935

Seeing Ourselves and Others: Developing Empathic Future Medical Leaders through Visual Art.

Speaker: Joyce Zazulak, McMaster University, Hamilton ON

Objectives: At the end of the session, the participants will be able to:

  • Understand of the role of the arts in medical education
  • Demonstrate the role of the arts in development of empathetic and compassion healthcare providers
  • Explore the role that art may have in the development of the reflective practioner

0935-0945

Q & A Session

0935-1015

Refreshment Break with Exhibitors

Chair: TBD, TBD

1015-1045

Narrative Ethics in Genetics

Speaker: Vassiliki Rahimzadeh, University of Toronto, Toronto ON

Objectives: At the end of the session, the participants will be able to:

  •  

1050-1100

Q & A Session

1045-1125

 

Integrating the medical humanities into competency-based training programs in medical genetics: opportunities and challenges

Speaker: Aspasia Karalis, Service de génétique médicale, CHU Sainte-Justine, Montréal QC

Objectives: At the end of the session, the participants will be able to:

  • Summarize the key characteristics of competency-based medical education;
  • Identify potential benefits of integrating the humanities as means of teaching and evaluating the development and acquisition of competencies in professionalism, communication, patient advocacy and leadership;
  • Evaluate the opportunities and challenges for integrating the medical humanities into a competency-based, medical genetics curriculum at their respective academic centres.

1125-1145

Q & A Session

1145-1200

Closing Remarks

WORKSHOP

1200-1215

Pick up Box Lunch

Montreal C

1215-1415

Session 1: Workshop on Social Media

Moderator: Malgorzata Joanna Nowaczyk, Division of Genetics, McMaster University Medical Centre, Hamilton ON

Speakers: Julie Lauzon, Department of Medical Genetics, Alberta Children’s Hospital, Calgary AB; Oana Caluseriu, Department of Medical Genetics, University of Alberta, Edmonton AB; Tyler Peikes, Winnipeg MB

Objectives: At the end of the session, the participants will be able to:

  • Discuss the types of social medial useful and used in medical practice
  • Be aware of patients’ perceptions and uses of social media
  • Be aware of the ethical implications of using social medial in patient communication, research, education and medical practice
  • Consider establishing and participating in a working group to develop a CCMG policy on the use of social media in the practice of clinical genetics

Montreal C

 

1415-1430

Q & A Session